US Patent Litigations are now available. Check here

Explore patent oppositions filed by Galderma Holding against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Jun 12, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3079714Long Lasting Effect Of New Botulinum Toxin FormulationsMEDY TOXAug 24, 2021
EP2674147Hyaluronic Acid-Based Gels Including Anesthetic AgentsALLERGAN INDUSTRIESep 30, 2020